- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Incretin-Based Therapies on Adipokines and Adiponectin
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2021, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2021-10-10
DOI
10.1155/2021/3331865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases
- (2021) Ali Dakroub et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
- (2021) Daria Skuratovskaia et al. Frontiers in Genetics
- Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: A meta-analysis of randomized controlled trials
- (2021) Luis E. Simental-Mendía et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Roles of leptin and resistin in metabolism, reproduction and leptin resistance
- (2020) D.A. Zieba et al. DOMESTIC ANIMAL ENDOCRINOLOGY
- Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths — Selected Counties and Indian Reservations, United States, 2002–2015
- (2020) Jasmin Divers et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Basic Mechanisms of Diabetic Heart Disease
- (2020) Rebecca H. Ritchie et al. CIRCULATION RESEARCH
- Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
- (2020) Jonatan Barrera‐Chimal et al. DIABETES OBESITY & METABOLISM
- Resistin in metabolism, inflammation, and disease
- (2020) Deeksha Tripathi et al. FEBS Journal
- Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
- (2020) Miaomiao Jin et al. Open Medicine
- Leptin suppresses development of GLP-1 inputs to the paraventricular nucleus of the hypothalamus
- (2020) Jessica E Biddinger et al. eLife
- Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia
- (2019) Katarzyna Neubauer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Leptin resistance: underlying mechanisms and diagnosis
- (2019) Olga Gruzdeva et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity
- (2019) Alina Yu. Babenko et al. Journal of Diabetes Research
- Metabolic effects of antidiabetic drugs on adipocytes and adipokine expression
- (2019) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis
- (2019) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus
- (2019) Wei Liang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
- (2019) Stephanie Eid et al. DIABETOLOGIA
- Circulating Resistin Is Associated with Plasma Glucagon-Like Peptide-1 in Cirrhotic Patients with Hepatitis C Virus Genotype-4 Infection
- (2019) Doaa M. Ibrahim et al. ENDOCRINE RESEARCH
- GLP‐1 induces alpha cell proliferation and overrides leptin suppression induced by negative energy balance in vagotomized rats
- (2019) Tiago Morais et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- High molecular weight adiponectin reduces glucolipotoxicity-induced inflammation and improves lipid metabolism and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes
- (2019) Gautam Kumar Pandey et al. ATHEROSCLEROSIS
- Exercise Reduces Insulin Resistance in Type 2 Diabetes Mellitus via Mediating the lncRNA MALAT1/MicroRNA-382-3p/Resistin Axis
- (2019) Sui-Xin Liu et al. Molecular Therapy-Nucleic Acids
- Insulin sensitivity, leptin, adiponectin, resistin, and testosterone in adult male and female rats after maternal-neonatal separation and environmental stress
- (2018) Hershel Raff et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin
- (2018) O.M. Abdelwahed et al. BRAIN RESEARCH BULLETIN
- The role of adipokines in skeletal muscle inflammation and insulin sensitivity
- (2018) Thomas Nicholson et al. Journal of Inflammation-London
- Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions
- (2018) F.P.M. O’Harte et al. PEPTIDES
- The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer
- (2018) Marta B. Wysocka et al. Frontiers in Physiology
- Dynamics of adipose tissue turnover in human metabolic health and disease
- (2018) Ursula White et al. DIABETOLOGIA
- Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models
- (2018) Ashfaq Ahmad et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial
- (2017) Li Shi et al. Obesity Research & Clinical Practice
- A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus
- (2017) Huibiao Quan et al. Experimental and Therapeutic Medicine
- Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis
- (2017) Shunqin Wang et al. Brazilian Oral Research
- Leptin/Adiponectin Ratios Using Either Total Or High-Molecular-Weight Adiponectin as Biomarkers of Systemic Insulin Sensitivity in Normoglycemic Women
- (2017) Carolina Bravo et al. Journal of Diabetes Research
- Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice
- (2017) Andreas Lindqvist et al. Frontiers in Endocrinology
- Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study
- (2016) Olivia M. Farr et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- Ghrelin: A New Incretin Enhancer Therapy?: Figure 1
- (2015) Vincent G. DeMarco et al. DIABETES
- Liraglutide treatment causes upregulation of adiponectin and downregulation of resistin in Chinese type 2 diabetes
- (2015) Dongmei Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling
- (2015) Charlotte C Ronveaux et al. JOURNAL OF NUTRITION
- Inverse association between maternal 25OHD level and cord GLP-1/GIP concentrations
- (2015) Shimpei Niwa et al. PEDIATRIC RESEARCH
- Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor
- (2015) Felicia Goldsmith et al. PLoS One
- Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis
- (2015) Xiaoyan Song et al. Scientific Reports
- Apelin and energy metabolism
- (2015) Chantal Bertrand et al. Frontiers in Physiology
- Ghrelin
- (2015) T.D. Müller et al. Molecular Metabolism
- Ghrelin Is a Novel Regulator of GLP-1 Secretion
- (2014) Jeffrey Gagnon et al. DIABETES
- Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
- (2014) Gonzalo Díaz-Soto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss
- (2014) E W Iepsen et al. INTERNATIONAL JOURNAL OF OBESITY
- Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study
- (2014) Yumie Takeshita et al. Journal of Diabetes Investigation
- Expression of CTRP3, a Novel Adipokine, in Rats at Different Pathogenic Stages of Type 2 Diabetes Mellitus and the Impacts of GLP-1 Receptor Agonist on It
- (2014) Xin Li et al. Journal of Diabetes Research
- Glucagon-like Peptide-1 Upregulates Visfatin Expression in 3T3-L1 Adipocytes
- (2013) R. Liu et al. HORMONE AND METABOLIC RESEARCH
- Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
- (2013) L van Bloemendaal et al. JOURNAL OF ENDOCRINOLOGY
- Effects of Weight Loss and Exercise on Apelin Serum Concentrations and Adipose Tissue Expression in Human Obesity
- (2013) Joanna Krist et al. Obesity Facts
- Elevated plasma visfatin concentrations in patients with community-acquired pneumonia
- (2013) Wei Hu et al. PEPTIDES
- Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents
- (2013) Jean-Sébastien Wattez et al. PEPTIDES
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin
- (2012) Minh Nguyet Pham et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Visfatin and resistin: Mediators of the pleiotropic effects of incretins?
- (2012) Eitaro Nakashima Journal of Diabetes Investigation
- Adipokines: Biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity
- (2011) Javier Conde et al. BIOFACTORS
- Resistin: functional roles and therapeutic considerations for cardiovascular disease
- (2011) Md S Jamaluddin et al. BRITISH JOURNAL OF PHARMACOLOGY
- An Isoform of Decorin Is a Resistin Receptor on the Surface of Adipose Progenitor Cells
- (2011) Alexes C. Daquinag et al. Cell Stem Cell
- Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
- (2011) Roberta Baetta et al. DRUGS
- in vivoSuppression of Visfatin by Oral Glucose Uptake: Evidence for a Novel Incretin-Like Effect by Glucagon-Like Peptide-1 (GLP-1)
- (2011) Margarita Bala et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes
- (2011) Shunming Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
- (2010) M. C. Bunck et al. DIABETES CARE
- Visfatin regulates genes related to lipid metabolism in porcine adipocytes
- (2010) C. C. Yang et al. JOURNAL OF ANIMAL SCIENCE
- Modulation of the Glucagon-Like Peptide-1 Receptor Signaling by Naturally Occurring and Synthetic Flavonoids
- (2010) D. Wootten et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Visfatin, glucose metabolism and vascular disease: a review of evidence
- (2010) Pedro Saddi-Rosa et al. Diabetology & Metabolic Syndrome
- Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression
- (2009) Le Thi Kim Chung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells
- (2009) James E P Brown et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Adipokines as novel modulators of lipid metabolism
- (2009) Francisca Lago et al. TRENDS IN BIOCHEMICAL SCIENCES
- Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
- (2008) Cédric Dray et al. Cell Metabolism
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes
- (2008) O. Kunduzova et al. FASEB JOURNAL
- Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells
- (2008) Nicoletta Di Simone et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Unknown
- (2008) Katja Rabe et al. MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started